Back

Vivos targets $3.6 million annual savings in Q4 2026 restructuring

Verifying
  • Vivos Therapeutics announced a restructuring and cost-reduction plan targeting annual savings.
  • $3.6 million in estimated annual savings is expected to begin in Q4 2026.
  • Referrals to Vivos' Las Vegas centers rose approximately threefold from June 1 through September 27.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Vivos targets $3.6 million annual savings in Q4 2026 restructuring - CoinPost Terminal